By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panelists have a neutral to bearish sentiment on Goldman Sachs (GS), with the main concern being its reliance on cyclical deal flow and potential headwinds from regulatory capital requirements under Basel III Endgame revisions. While some see opportunities in private credit growth and risk management prowess, the consensus is that GS's stock price is vulnerable to multiple contraction if deal activity slows or rates remain elevated.
Risk: The single biggest risk flagged is the potential compression of GS's earnings due to a slowdown in deal activity or elevated rates, which could lead to a multiple contraction of the stock price.
Opportunity: The single biggest opportunity flagged is the growth in private credit assets under management, which could provide a secular tailwind to offset cyclical fee risks.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
The Goldman Sachs Group, Inc. (NYSE:GS) is one of the stocks Jim Cramer shared his thoughts on as he discussed Big Tech’s AI spending. A caller asked how the company will do with “giant IPOs in the pipeline,” and Cramer replied:
They’re going to be the big winner. They’re going to be the big winner in IPOs and in M&A… And that’s why I think it’s a huge position for me, my Charitable Trust, and I think that it’s going higher.
Stock market data. Photo by Burak The Weekender on Pexels
The Goldman Sachs Group, Inc. (NYSE:GS) provides financial services, including investment banking, asset and wealth management, and banking solutions. Cramer highlighted the firm’s “specialty” during the April 10 episode, as he said:
Let’s get to our game plan for next week. Alright, my Charitable Trust has a very big, long, very big position in, well, in Goldman Sachs. Okay, that’s my alma mater. And when it reports on Monday, barring some serious Iranian action that causes a spike in the price of oil this weekend, I think you’ll see a solid set of numbers and a good reaction to the numbers that Goldman Sachs prints. Now, I’ve gotta tell you, this judgment does stem a little bit from my time at Goldman. Why? Because that’s where I learned to manage and profit from risk. It’s what the firm does best is manage risk. And this volatile market, like the one we are having, that’s Goldman’s specialty.
While we acknowledge the potential of GS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years** **
Disclosure: None. Follow Insider Monkey on Google News.
Four leading AI models discuss this article
"Goldman Sachs' current valuation fully prices in an IPO recovery, leaving little margin for error if deal flow remains muted by persistent interest rate volatility."
Cramer’s endorsement of Goldman Sachs (GS) centers on a recovery in investment banking fees from IPOs and M&A, which have been stagnant for two years. While the cyclical argument is sound—deal flow is indeed thawing—the market is already pricing in a 'soft landing' scenario. GS currently trades at roughly 1.3x price-to-book, a premium that assumes flawless execution in their pivot toward asset management. If the Fed maintains 'higher for longer' rates, capital markets activity will remain suppressed, and the firm’s heavy reliance on trading revenue will be insufficient to offset the lack of advisory fee growth, leaving the stock vulnerable to a multiple contraction.
The strongest case against this is that a sustained period of high interest rates actually benefits Goldman’s trading desk and net interest income, potentially decoupling their earnings from the sluggish IPO market.
"GS benefits from volatility and deal hopes, but Marcus headwinds and lagging IB fees cap upside without confirmed fee inflection."
Cramer's bullish call on GS ahead of Q1 earnings (April 15, 2024) hinges on its risk-management prowess in volatile markets and a rebound in IPOs/M&A, where GS leads with top IB league tables. FICC and equities trading revenues have indeed powered recent beats (Q4 '23 up 35% YoY), supporting his thesis. However, the article glosses over GS's persistent consumer banking drag—Marcus losses widened—and tepid IB fees (down 27% YoY in Q4), lagging peers like JPMorgan. High rates could delay the IPO pipeline (e.g., Reddit, Stripe still private), and volatility is mean-reverting. Solid numbers likely, but no re-rating catalyst without fee acceleration.
If volatility persists amid AI capex and election uncertainty, GS's trading franchise could crush estimates again, driving shares to $450+ as Cramer predicts.
"GS is a near-term vol and deal-flow play, not an AI story—and both catalysts are binary and time-sensitive."
Cramer's bullish call on GS rests on two cyclical tailwinds: IPO/M&A activity tied to AI euphoria, and volatility favoring risk management. The timing matters—he's anchoring to Monday earnings (April 10). However, the article conflates two separate theses: GS as a vol-play (valid in choppy markets) versus GS as a structural AI beneficiary (weaker). Investment banking fees are cyclical and front-loaded; if IPO pipelines disappoint post-earnings or AI spending moderates, the multiple compresses quickly. GS trades at ~1.3x book value—not cheap for a firm whose earnings depend on deal flow that could evaporate.
If the 'giant IPO pipeline' fails to materialize post-earnings, or if volatility normalizes as rate-cut expectations solidify, GS loses both its cyclical and vol-hedging appeal simultaneously. The article provides zero evidence the pipeline is actually robust.
"GS's upside hinges on a sustained capital-markets rebound; without that, earnings growth and valuation upside are constrained."
Jim Cramer's take pins GS as a 'big winner' from IPOs, M&A and AI-driven deal flow. But that's a cyclical, fee‑dependent thesis. Goldman’s earnings leverage hinges on a healthy capital markets backdrop; if IPO pipelines thin, M&A slows, or rates stay elevated, fee pools compress and earnings miss consensus. The article glosses over counter risks: credit and market risk from a downturn, regulatory scrutiny on investment banking and advisory fees, competition from boutiques and nonbank lenders, and GS’s reliance on wholesale funding in some segments. Also, AI spend by clients may not translate into proportionate deal activity for Goldman. Expect range-bound trading with downside risk if markets turn.
Even if AI spend accelerates, deal flow may lag; the market price of GS may already reflect a cyclical recovery, and a downturn could crush fee income and leverage returns.
"Basel III capital requirements represent a structural valuation anchor that outweighs the cyclical IPO recovery thesis."
Claude, you’re right that the 'AI beneficiary' narrative is thin, but you’re ignoring the regulatory capital angle. Basel III Endgame revisions are the real overhang for GS. If capital requirements tighten, GS’s ROE-driven valuation model breaks regardless of deal flow. While others focus on the cyclical IPO thaw, they’re missing that GS is currently forced to hoard capital for compliance rather than deploying it for growth. That’s a structural anchor on the stock price, not just a cyclical one.
"GS's robust capital buffers and private credit growth diminish Basel III overhang and provide non-cyclical revenue stability."
Gemini, Basel III Endgame is real but overstated—GS's CET1 ratio sits at 14.5% (well above 13.25% req post-revisions), per Q4 filings, buffering any tweaks. Tying to Grok's Marcus drag: shedding consumer banking frees capital for high-ROE trading/IB. Unflagged: GS's private credit AUM up 20% YoY to $110B, a secular tailwind muting cyclical fee risks.
"Private credit is a long-term structural offset, not a Q1 earnings catalyst—GS still needs IPO/M&A to accelerate immediately to justify Cramer's bull case."
Grok's private credit AUM growth is material, but it's a red herring for near-term earnings. $110B AUM at typical 1-2% management fees adds ~$1.1-2.2B annual revenue—meaningful, but GS's Q4 IB fees collapsed 27% YoY. Private credit scales slowly; it doesn't offset a stalled IPO market in Q1. The real question: does management guide to fee recovery post-April 15, or does private credit become the 'story' masking weak traditional banking?
"Endgame risk could be a persistent headwind to ROE and buybacks, not a transient overhang, keeping valuation multiples compressed even if CET1 remains strong."
Gemini’s Basel III Endgame concern is plausible, but Grok’s refutation ignores potential RWAs expansions and capital policy drag. If risk weights rise for private credit, securitized products, or long-duration assets, ROE won't stay at 14.5% and buybacks stay capped, keeping the 1.3x book pricey. The real risk: Endgame could become a persistent headwind even in a mid-cycle upswing, not just a one-off overhang.
The panelists have a neutral to bearish sentiment on Goldman Sachs (GS), with the main concern being its reliance on cyclical deal flow and potential headwinds from regulatory capital requirements under Basel III Endgame revisions. While some see opportunities in private credit growth and risk management prowess, the consensus is that GS's stock price is vulnerable to multiple contraction if deal activity slows or rates remain elevated.
The single biggest opportunity flagged is the growth in private credit assets under management, which could provide a secular tailwind to offset cyclical fee risks.
The single biggest risk flagged is the potential compression of GS's earnings due to a slowdown in deal activity or elevated rates, which could lead to a multiple contraction of the stock price.